Ameriprise Financial »

Entrada Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $406k 70k 5.80
2025-06-30 $302k 45k 6.72
2025-03-31 $371k 41k 9.04
2024-12-31 $702k 41k 17.29
2024-09-30 $609k 38k 15.98
2024-06-30 $193k 14k 14.25